[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

Global Statistics Representing Veterinary Dermatology Drugs Market Scenario

Atopic dermatitis is chronic skin disease associated with allergies which is caused by harmless substances like grass, mold spores, house dust mites, and other environmental allergens. Surge in prevalence of chronic skin disorders such as chewing, biting, rubbing is driving the growth of market. Furthermore, high presence of cattle and buffalo suffering from of lumpy skin disease (LSD) in European countries is major reason for boosting the growth of market. For instance, since 2012, LSD has been spread from Africa and the Middle East into south-eastern Europe, affecting European Union (EU) Member countries. Numerous autoimmune and immune-mediated cutaneous diseases such as atopic in cat and dog across the globe is in companion animals is fuelling the growth of market. Surge in number of incidence of anthrax in cattle, deer, cattle, goats, and sheep is supporting the growth of market.

Global veterinary dermatology market is expected to reach USD 2,353.9 million in 2026 from USD 3,525.7 million in 2018 at a CAGR of 5.5% during the forecast period 2019–2026

Segmentation insight

The veterinary dermatology drugs market is segmented into drug, animal type and end users.

On the basis of drug the veterinary dermatology drugs market is segmented into non-steroidal anti-inflammatory drugs (NSAIDS), antibiotics, and veterinary antifungal drug. Antibiotics veterinary medicine segment is expected to hold major market share owing to most of skin diseases caused by various bacteria.

Based on the animal type the market is segmented into large animals and small animals. High prevalence of dermatological disorders in small animals such as dog and cat as compared other animal, thus, small animals segment is dominated market and expected to grow in forecast period.

On the basis of end users the market is segmented into veterinary hospitals, veterinary clinics. Veterinary clinics is expected to hold major market share owing to control infectious animal diseases and thus reduce morbidity and mortality rate of animals. Veterinary clinics is cost effective then veterinary hospital thus, large number of patient visit the clinic.

Key Finding

Key-Finding

Regional Insight

Geographically, veterinary dermatology drugs market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa (LAMEA).

North America is dominating the market & is expected to continue its dominance over the forecast period. This is attributed to increasing adoption of companion animal in developed countries such as U.S., Canada and increasing spending on pet care in this region is boosting the growth of market. For instance, as per American Pet Products Association (APPA) data states that 68.0% of US households, or approximately 86.4 million homes, have at least one pet. However, high prevalence of pruritus, sores, alopecia, masses, eruptions, scales, seborrhea, pustules, and draining tracts in companion animals is fuelling the market growth. Furthermore, increasing technology in veterinary medicine that has lengthen lifespan of veterinary animals is another region which positively influence the market.

Europe is expected to witness second leading region for veterinary dermatology drugs market. Different dermatological association in Europe region which is increasing the awareness about the skin disease is boosting the growth of market. For instance, European Society of Veterinary Dermatology, is a non-profit organization that supports the development of veterinary dermatology throughout Europe and provides funding for both research and educational programs such as workshops. Presence of leading animal care player such as International GmbH.(France), Vetoquinol S.A.(France), and Virbac(France). is positively impact on market.

What will be the Future Developments in Veterinary Dermatology Drugs Market?

Future-Developments-in-Veterinary-Dermatology-Drugs-Market

Our Report Covers

  • Historical inferences, findings & analysis of the market from 2016 to 2018
  • Projections and performance forecast analysis for the future from 2019 to 2026
  • Production and consumption point of view (POV) analysis
  • Market drivers, restraint and opportunity analysis, to define market dynamics covering industry, regulatory, innovation, technological & pricing trends
  • Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability, and prospect

Key Players

Some of the key players in global veterinary dermatology drugs market include Bayer HealthCare Animal Health Inc. (U.S.), Boehringer Ingelheim Vetmedica, Inc.(U.S.), Ceva(France), Zoetis Inc.(U.S.), Elanco(U.S.), IDEXX Laboratories(U.S.), Boehringer Ingelheim International GmbH.(France), Vetoquinol S.A.(France), and Virbac(France).

Veterinary Dermatology Drugs Market Segmentation

By Drug

  • Non-steroidal anti-inflammatory drugs (NSAIDS)
  • Antibiotics
  • Veterinary antifungal drug

By Animal Type

  • Large animals
  • Small animals

By End Users

  • Veterinary Hospitals
  • Veterinary Clinics

By Regional

 America

o    North America

  • U.S.
  • Canada
  • Mexico

o    South America

       Europe

  • Western Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Rest of Western Europe

o    Eastern Europe

      Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific

     The Middle East & Africa

  • The Middle East
  • Saudi Arabia
  • UAE
  • Qatar
  • Rest of the Middle East

     Africa

What Report Covered By Veterinary Dermatology Drugs Market

Report-Covered

Frequently Asked Questions (FAQs)

Global veterinary dermatology market is expected to reach USD 2,353.9 million in 2026 from USD 3,525.7 million in 2018 at a CAGR of 5.5% during the forecast period 2019–2026
North America is expected to hold the highest market share in Veterinary Dermatology Drugs Market.
In 2018 Global Veterinary Dermatology Drugs Market was valued at USD 3,525.7 million.
HealthCare Animal Health Inc., Boehringer Ingelheim Vetmedica, Inc., Ceva, Zoetis Inc., Elanco, IDEXX Laboratories are the top players in Veterinary Dermatology Drugs Market.
Increasing technology in veterinary medicine are the key factor expected to drive the Veterinary Dermatology Drugs Market during forecast period.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times, and included in every purchase.


Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports